Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Paltimatrectinib

Paltimatrectinib (PBI-200) is a potent tyrosine kinase inhibitor with anticancer activity that inhibits myosin-related kinase A (TrkA) .Paltimatrectinib is used in the study of bladder, breast and colorectal cancers.

Product Specifications

CAS Number

2353522-15-1

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

434.37

Molecular Formula

C20H15F5N6

Notes

Research use only, not for human use.

Receptor

Tyrosine Kinases | Trk receptor

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Kiatomab
HY-P991730 1 Each

Kiatomab

Sign In for Pricing
View Details
Glycol Chitosan discontinued. See 207000
297123-01 1 g

Glycol Chitosan discontinued. See 207000

Sign In for Pricing
View Details
Glycol Chitosan discontinued. See 207000
297123-02 2 g

Glycol Chitosan discontinued. See 207000

Sign In for Pricing
View Details
Glycol Chitosan discontinued. See 207000
297123-03 5 g

Glycol Chitosan discontinued. See 207000

Sign In for Pricing
View Details
Glycol Chitosan discontinued. See 207000
297123-04 10 g

Glycol Chitosan discontinued. See 207000

Sign In for Pricing
View Details
Glycol Chitosan discontinued. See 207000
297123-05 20 g

Glycol Chitosan discontinued. See 207000

Sign In for Pricing
View Details